NASDAQ:COSM Cosmos Health (COSM) Stock Price, News & Analysis $0.76 -0.01 (-1.30%) (As of 10/31/2024 ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends About Cosmos Health Stock (NASDAQ:COSM) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Cosmos Health alerts:Sign Up Key Stats Today's Range$0.76▼$0.7750-Day Range$0.72▼$1.2852-Week Range$0.47▼$1.65Volume58,841 shsAverage Volume867,984 shsMarket Capitalization$12.87 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingBuy Company OverviewCosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors. It sells its products through independent wholesale distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.Read More… Protect Your Bank Account with THESE 4 Simple Steps (Ad)Starting as soon as a few months from now, the United States government will make a sweeping change to bank accounts nationwide. It will give them unprecedented powers to control your bank account.Learn these 4 simple steps and protect your savings before it’s too late. Cosmos Health Stock Analysis - MarketRank™See Top Rated MarketRank™ Stocks31st Percentile Overall ScoreCOSM MarketRank™: Cosmos Health scored higher than 31% of companies evaluated by MarketBeat, and ranked 813th out of 993 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Cosmos Health.Read more about Cosmos Health's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Cosmos Health are expected to grow in the coming year, from ($0.48) to ($0.05) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cosmos Health is -0.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cosmos Health is -0.34, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCosmos Health has a P/B Ratio of 0.36. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Cosmos Health's valuation and earnings. Short Interest5.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted2.97% of the float of Cosmos Health has been sold short.Short Interest Ratio / Days to CoverCosmos Health has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cosmos Health has recently decreased by 12.75%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldCosmos Health does not currently pay a dividend.Dividend GrowthCosmos Health does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted2.97% of the float of Cosmos Health has been sold short.Short Interest Ratio / Days to CoverCosmos Health has a short interest ratio ("days to cover") of 1.1, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Cosmos Health has recently decreased by 12.75%, indicating that investor sentiment is improving significantly. News and Social Media1.9 / 5News Sentiment0.46 News SentimentCosmos Health has a news sentiment score of 0.46. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.68 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 6 news articles for Cosmos Health this week, compared to 6 articles on an average week.MarketBeat Follows2 people have added Cosmos Health to their MarketBeat watchlist in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Cosmos Health insiders have not sold or bought any company stock.Percentage Held by Insiders18.74% of the stock of Cosmos Health is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 12.61% of the stock of Cosmos Health is held by institutions.Read more about Cosmos Health's insider trading history. Receive COSM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cosmos Health and its competitors with MarketBeat's FREE daily newsletter. Email Address COSM Stock News HeadlinesHoroscope Today, October 30, 2024: Read your today's astrological predictions for all zodiac signsOctober 30 at 2:13 AM | msn.comCosmos Health files to sell 9.75M shares of common stock for holdersOctober 30 at 2:13 AM | markets.businessinsider.comThe real reason Elon is fully endorsing TrumpElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to humanity, there is a war being waged on Elon Musk. This war has nothing to do with X, Elon’s stance on immigration or his support for Donald Trump. October 31, 2024 | Porter & Company (Ad)Analyzing Cosmos Health (NASDAQ:COSM) & Sinopharm Group (OTCMKTS:SHTDY)October 29 at 4:04 AM | americanbankingnews.comCosmos Health files secondary offering of sharesOctober 28 at 9:47 PM | msn.comCosmos Healthcare Launches Innovative AI Solutions for Neurological CareOctober 26, 2024 | msn.comCosmos Health (NASDAQ:COSM) & Sinopharm Group (OTCMKTS:SHTDF) Critical ComparisonOctober 22, 2024 | americanbankingnews.comNASA captures star duo spraying plasma a quarter-trillion milesOctober 21, 2024 | msn.comSee More Headlines COSM Stock Analysis - Frequently Asked Questions How have COSM shares performed this year? Cosmos Health's stock was trading at $1.41 on January 1st, 2024. Since then, COSM stock has decreased by 46.1% and is now trading at $0.76. View the best growth stocks for 2024 here. How were Cosmos Health's earnings last quarter? Cosmos Health Inc. (NASDAQ:COSM) posted its quarterly earnings data on Tuesday, August, 20th. The company reported ($0.09) EPS for the quarter, beating the consensus estimate of ($0.14) by $0.05. The company had revenue of $13.21 million for the quarter, compared to analyst estimates of $15.25 million. Cosmos Health had a negative net margin of 38.19% and a negative trailing twelve-month return on equity of 5.83%. When did Cosmos Health's stock split? Cosmos Health's stock reverse split on the morning of Thursday, December 15th 2022. The 1-25 reverse split was announced on Thursday, December 15th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, December 15th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split. How do I buy shares of Cosmos Health? Shares of COSM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of Cosmos Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Cosmos Health investors own include Meta Platforms (META), NVIDIA (NVDA), Adobe (ADBE), Broadcom (AVGO), CrowdStrike (CRWD), Arista Networks (ANET) and Builders FirstSource (BLDR). Company Calendar Last Earnings8/20/2024Today10/31/2024Next Earnings (Estimated)11/19/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Medical Distribution Sub-IndustryWholesale Current SymbolNASDAQ:COSM CUSIPN/A CIK1474167 Webwww.cosmosholdingsinc.com Phone(312) 536-3102FaxN/AEmployees123Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($2.26) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-18,540,000.00 Net Margins-38.19% Pretax Margin-38.31% Return on Equity-5.83% Return on Assets-3.29% Debt Debt-to-Equity Ratio0.07 Current Ratio1.35 Quick Ratio1.17 Sales & Book Value Annual Sales$56.45 million Price / Sales0.23 Cash FlowN/A Price / Cash FlowN/A Book Value$2.13 per share Price / Book0.36Miscellaneous Outstanding Shares16,933,000Free Float17,076,000Market Cap$12.88 million OptionableOptionable Beta5.70 These 7 Stocks Will Be Magnificent in 2024With average gains of 150% since the start of 2023, now is the time to give these stocks a look and pump up your 2024 portfolio.Get This Free Report This page (NASDAQ:COSM) was last updated on 10/31/2024 by MarketBeat.com Staff From Our PartnersTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsoredtop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)AI was by far the biggest tech investing trend right now. But Ross Givens says the #1 artificial intelligen...Traders Agency | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | Sponsored“Buffett Indicator” Predicts 62% Stock Market CrashThe last time the "Buffett Indicator" flashed this red was in 2000 - right before the market crashed 50%.Behind the Markets | SponsoredTrump or Kamala? It may come down to this strange twist…Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia? ...Porter & Company | Sponsored625,000% GainThe recent pullback in the crypto markets has left many investors in full-on panic mode, convinced the bull ru...Crypto Swap Profits | SponsoredGold at $2,600... But This Stock Gives You More for Under $20Gold just soared over $2,600 an ounce. But what if I told you there's a way to get exposure to MORE than an...Monument Traders Alliance | SponsoredCNBC’s ‘Prophet’ issues urgent Fed warning"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cosmos Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cosmos Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.